Nrf2 Activation as Target to Implement Therapeutic Treatments

Frontiers in Chemistry - Switzerland
doi 10.3389/fchem.2015.00004
Full Text
Abstract

Available in full text

Categories
Chemistry
Date
Authors
Publisher

Frontiers Media SA

Related search

Keap1 Cysteine 288 as a Potential Target for Diallyl Trisulfide-Induced Nrf2 Activation

PLoS ONE
Multidisciplinary
2014English

Lysosomes as a Therapeutic Target

Nature Reviews Drug Discovery
MedicineDrug DiscoveryPharmacology
2019English

CD38 as a Therapeutic Target

Molecular Medicine
Molecular MedicineGeneticsMolecular Biology
2006English

Candida Albicansdimorphism as a Therapeutic Target

Expert Review of Anti-Infective Therapy
VirologyInfectious DiseasesMicrobiology
2012English

Tumor Evolution as a Therapeutic Target

Cancer Discovery
Oncology
2017English

GPR35 as a Novel Therapeutic Target

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2011English

TRAF6 Activation in Multiple Myeloma: A Potential Therapeutic Target

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2012English

Prostanoid Receptor EP2 as a Therapeutic Target

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2013English

LncRNA as a Therapeutic Target for Angiogenesis

Current Topics in Medicinal Chemistry
MedicineDrug Discovery
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy